Cargando…
Treating patients with multiple sclerosis during the COVID-19 pandemic: Assessing the expert recommendations
Autores principales: | Guevara, Carlos, Villa, Eduardo, Rosas, Carlos Silva, Diaz, Violeta, Naves, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7245233/ https://www.ncbi.nlm.nih.gov/pubmed/32464582 http://dx.doi.org/10.1016/j.msard.2020.102224 |
Ejemplares similares
-
Mild COVID-19 infection in a patient with multiple sclerosis and severe depletion of T-lymphocyte subsets due to alemtuzumab
por: Guevara, Carlos, et al.
Publicado: (2020) -
Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
por: Oreja-Guevara, Celia, et al.
Publicado: (2023) -
Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
por: Berger, Thomas, et al.
Publicado: (2016) -
Prospective Assessment of No Evidence of Disease Activity-4 Status in Early Disease Stages of Multiple Sclerosis in Routine Clinical Practice
por: Guevara, Carlos, et al.
Publicado: (2019) -
Diagnosis and treatment of latent tuberculosis in patients with multiple sclerosis, expert consensus. On behalf of the Colombian Association of Neurology, Committee of Multiple Sclerosis
por: Navas, Carlos, et al.
Publicado: (2018)